Overview

Imaging assesses body composition organ fat and metabolic effects of nutrition interventions. Modalities include MRI CT and ultrasound for quantitative analysis. Imaging biomarkers support research on diet and metabolic health.

Body Composition

MRI and CT quantify visceral and subcutaneous fat and lean mass distribution. These measures relate to metabolic risk and treatment response. Standardized protocols enable comparability across studies.

Liver Fat and Metabolic Disease

MRI based proton density fat fraction quantifies hepatic steatosis non invasively. Imaging tracks changes with dietary and pharmacologic interventions. Quantitative imaging supports clinical trials and translational research.

Integration with Biomarkers

Combining imaging with metabolic and laboratory biomarkers enhances understanding of nutrition effects. Longitudinal imaging captures dynamic changes over time. Research imaging informs public health and clinical recommendations.